JAN 12, 2016 9:20 AM PST

Nisin ‘milkshake' kills cancer cells in mice

Nisin, a naturally occurring preservative found in many foods, is showing promise as a way to fight cancer and antibiotic-resistant bacteria.

Feeding rats a high-dose “nisin milkshake” killed 70 to 80 percent of head and neck tumor cells after nine weeks and extended survival, says Yvonne Kapila, professor at the University of Michigan School of Dentistry.
 
"Mother Nature has done a lot of the research for us-it's been tested for thousands of years," says Yvonne Kapila.

The dosage of 800 mg/kg given to mice would translate to a pill a little bigger than a third of an Advil per kilogram of body weight for people.

While promising, it’s too early to say if nisin will act the same way in humans, Kapila says.

Nisin also fights deadly bacteria such as antibiotic-resistant MRSA. In a recent review paper, Kapila’s group looked at experimental uses of nisin to treat 30 different types of cancer; infections of the skin, respiratory system, and abdomen; and oral health problems.

“To date, nobody has found bacteria from humans or living animals that are resistant to nisin,” Kapila says.

Two things make nisin lethal to bacteria: It binds to a static area of bacteria, which gives it the opportunity to work before bacteria changes into an antibiotic-resistant superbug, and it kills biofilms—colonies of bacteria that group together into a fortress that thwarts antibiotics.

Another positive is that nisin has withstood the test of time, Kapila says. “Mother Nature has done a lot of the research for us—it’s been tested for thousands of years.”

The next step will be to test it in in a clinic setting.

“The application of nisin has advanced beyond its role as a food biopreservative,” Kapila says. “Current findings and other published data support nisin’s potential use to treat antibiotic-resistant infections, periodontal disease, and cancer."

The findings appear in the Journal of Antimicrobial Chemotherapy.

This article was originally published on futurity.org.
About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
DEC 16, 2019
Cell & Molecular Biology
DEC 16, 2019
When Migrating, Cancer Cells Choose the Path of Least Resistance
Cancer becomes most deadly when it has metastasized - when cancerous cells move away from the site where cancer started growing....
DEC 23, 2019
Health & Medicine
DEC 23, 2019
Are Popular Gyms Promoting Indoor Tanning?
You might assume that by now, most humans are aware of the dangers of indoor tanning beds. However, many popular gyms include tanning beds as a perk of mem...
DEC 25, 2019
Drug Discovery & Development
DEC 25, 2019
New Drug to Make Breast Cancer Treatment More Affordable
The US Food and Drug Administration has granted accelerated approval to new breast cancer drug, trastuzumab deruxtecan. The drug’s increasing recogni...
DEC 23, 2019
Technology
DEC 23, 2019
Can Artifical Intelligence Detect Leukemia?
Artificial intelligence has always been a hot topic of discussion in the medical sciences with a whirlwind of applications. However, know the latest curios...
JAN 16, 2020
Cancer
JAN 16, 2020
FLASH proton therapy: faster and more effective
A new technique called FLASH proposes a new type of radiation therapy. The technique is composed of an ultra-high dose rate of radiotherapy and uses electr...
JAN 21, 2020
Drug Discovery & Development
JAN 21, 2020
Drug Targets Gastrointestinal Cancer
The FDA has recently approved Ayvakit (avapritinib) for the treatment of unresectable and metastatic gastrointestinal stromal tumor (GIST) that occurs most...
Loading Comments...